Company news
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A (SSE:605033) news
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "Shaanxi Meibang Pharmaceutical Group Co.…
View Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A →
Press releases & updates
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on Providing Guarantees for Wholly-owned Subsidiaries
September 21, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on Capital Increase in a Wholly-owned Subsidiary and Establishment of a Hong Kong Wholly-owned Subsidiary
September 4, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on the Results of Shareholding Reduction by Shareholders
August 26, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on the Results of Shareholding Reduction by Certain Shareholders
August 19, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on Change of Shareholder Name
August 17, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
August 13, 2026
"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan for 2026
July 29, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 9, 2026
Announcement on Change in Names of Shareholders
June 5, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 22, 2026
Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Shaanxi Jurisdiction and 2025 Annual Performance Briefing
May 13, 2026
Announcement on Main Operating Data for Q1 2026
April 29, 2026
Announcement on Confirmation of Daily Related Party Transactions in 2025 and Estimated Daily Related Party Transactions in 2026
April 28, 2026
Announcement on Abnormal Fluctuations in Stock Trading
February 27, 2026
Announcement on Risk Warning in Stock Trading
February 13, 2026
Announcement on Providing Guarantee for Wholly-owned Subsidiary
February 6, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 15, 2026
Announcement on Applying for Credit Lines to Banks
December 25, 2025
Announcement on Implementation of Dividend Distribution for the First Three Quarters of 2025
December 1, 2025
Report for Q3 2025
October 28, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 26, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 12, 2025
Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association" and Some Corporate Systems
August 26, 2025
Announcement on Result of Shareholding Reduction by Partial Shareholders
July 23, 2025
Indicative Announcement on Change in Shareholding Interests
July 18, 2025
Indicative Announcement on Progress in Shareholding Reduction by Shareholder and Disclosure of 1% Change in Shareholding Interests
July 8, 2025
Announcement on Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
June 17, 2025
Announcement on Share Reduction Plan for Shareholders
June 3, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on Attending 2025 Collective Reception Day for Investors of Listed Companies in Shaanxi Jurisdiction and 2024 Annual Performance Briefing
May 13, 2025
Report for Q1 2025
April 28, 2025
Notice on Convening the 2024 Annual General Meeting
April 25, 2025
Announcement on Cancellation of Partial Accounts for Raised Funds
February 6, 2025
Announcement on Serious Abnormal Fluctuations in Stock Trading
January 13, 2025
Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk Warning
January 10, 2025
Announcement on Resolution of the 4th Extraordinary General Meeting in 2024
December 30, 2024
Announcement on Redemption at Maturity of Temporarily Idle Raised Funds Used for Cash Management
December 23, 2024
Announcement on Resolution of the 4th Meeting of the 3rd Board of Directors
December 13, 2024